Viewing Study NCT02035020


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-03-03 @ 12:03 AM
Study NCT ID: NCT02035020
Status: COMPLETED
Last Update Posted: 2017-04-21
First Post: 2014-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients
Sponsor: Azienda Policlinico Umberto I
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GIFT/1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators